Letter of Intent (LOI) Guidelines
Independent Research Awards
The Children’s Heart Foundation's 2023 Request for Applications (RFA) for Independent Research Awards is now closed.
This award mechanism is used to fund the most promising research that will advance the diagnosis, treatment, and prevention of congenital heart defects. For further details about what constitutes mission aligned research and a series of frequently asked questions (FAQs), please see the following webpage: Independent Grant FAQs.
2023 Process and Schedule
In contrast to prior years when a full application was initially required, researchers seeking funding for either RFA must now submit an initial Letter of Intent (LOI). The Children’s Heart Foundation made this change to reduce the initial time and effort required by applicants, their collaborators, and administrative research staff to apply for funding. The LOIs are due on May 15, 2023. Selected applicants will be invited to submit a full application no later than June 8, 2023.
- Independent Research Awards
- Up to $100,000 per year for two (2) years.
The Children’s Heart Foundation recognizes disparities based on race, ethnicity and gender exist in all areas of healthcare. For patients with congenital heart disease, it is well-known that certain racial and ethnic groups have worse outcomes. Among researchers, underrepresented minorities face additional challenges in obtaining research funding. These are important issues for the Children's Heart Foundation. Starting this year, we will begin collecting data on gender, race, and ethnicity for investigators who apply for research funding, as a part of our larger efforts to help address these disparities. We strongly encourage applications from underrepresented minority investigators and/or applications that focus on investigating disparities in patients with congenital heart disease.
All applicants for the Independent Research Awards must submit an LOI through our online application portal: https://proposalcentral.com/GrantOpportunities.asp?GMID=273
- March 29, 2023 – Independent Call for Research Proposals opens
- May 15, 2023 – Letter of Intent due by 5:00pm CST
- June 8, 2023 – Applicants notified as to whether or not they may submit a full application
- September 7, 2023 – Full Application (invite only) due by 5:00pm CST
- December 21, 2023 – Applicants notified as to a decision regarding funding
- January 2024 – Funds released for awardees
LOIs should be single-spaced and formatted in 11-point font with 1-inch margins. All applicants will first submit an LOI to be reviewed by the Research Leadership Committee, which consists of experienced investigators and lay members, and selected members of our Medical Advisory Counsel.
Applicants will be notified via email as to whether or not they are invited to submit a full application. For those invited to submit a full application, the due date will be September 7, 2023.
The LOI itself is limited to two (2) pages maximum. Areas of research in congenital heart disease include clinical, translational, population, behavioral, bioengineering, biotechnology, or public health.
LOI must include:
- Title of project
- Name, address, email, and telephone number of the Principal Investigator(s)*
- Names, titles, and institution of other key personnel – ex. mentors
- List of participating institution(s)
2. Lay summary
- 1/2 - 2/3 page
- The applicant should be aware that lay reviewers are involved in the review and scoring process.
3. Research Project
- 1 – 1.5 pages
- Scientific summary, including key details, such as a brief background and rationale (i.e., what is known and what is unknown), primary aims, summary of methods and data sources.
- Indicate whether the project will be basic science, translational, or clinical (or some combination thereof).
- Anticipated impact and prospects for future funding sources.
*The PI (only) should also submit his/her NIH bio-sketch (up to 4 pages; not counted in the 2-page LOI limit).
Need help or assistance using Proposal Central? Their help center information is below:
- 8:30am - 5:00pm Eastern Time (Monday through Friday)
- by phone (toll-free): 800 875 2562 (Toll-free U.S. and Canada) by or +1 703-964-5840 (Direct Dial International)
- by email: firstname.lastname@example.org